Becker's Healthcare October 4, 2022
Paige Twenter

Alexion Pharmaceuticals, a subsidiary of the drugmaker AstraZeneca, plans to acquire LogicBio Therapeutics, a gene therapy company.

AstraZeneca’s offer price is $2.07 per share, the company said in an Oct. 3 news release, making the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Former Bristol Myers CEO tapped as Novartis’ next board chair
The Power of Drug Discovery with Philip Tagari
Novartis raises forecasts as top drug sales beat Wall Street estimates
Pharma Pulse 4/23/24: Drug Discount Programs Poised to Change with New Tech, SpecialtyRx Savings Navigator to Enhance Affordability & more
AI Ushers in HPC Revival Says TACC’s Dan Stanzione

Share This Article